Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
54 Results for "
Pin1
" in MedChemExpress (MCE) Product Catalog:
Products (54)
54 Results for "Pin1" in MCE Product Catalog:
Cat. No.: HY-171334
CAS No.: 2957895-04-2
Research Areas:
(Rac)-P1D-34 is a Pin1 PROTAC degrader that recruits cereblon, with a DC50 of 177 nM. (Rac)-P1D-34 induces Pin1 degradation via proteasome- and ubiquitin-like modification-dependent pathways. (Rac)-P1D-34 upregulates ROS and DNA damage, downregulates the UPR pathway, and inhibits leukemia cell proliferation; it also sensitizes drug-resistant acute myeloid leukemia cells to Venetoclax (ABT-199) (HY-15531) by downregulating Mcl-1 levels. (Rac)-P1D-34 can be used in the research of acute myeloid leukemia [1] .
Cat. No.: HY-186219
Research Areas:
PIN1 ligand-3 (Compound I-1) is a PIN1 ligand. PIN1 ligand-3 serves as a Ligand for Target Protein for PROTAC for the synthesis of PIN1 PROTAC degraders, such as PROTAC PIN1 degrader-2 (HY-186218). PIN1 ligand-3 is applicable in cancer research [1].
Cat. No.: HY-164896
CAS No.: 3080918-74-4
PIN1 degrader-2 is a covalent PIN1 degrader with an IC50 of 4.1 nM. PIN1 degrader-2 induces a decrease in the thermal stability of PIN1 and triggers concentration-dependent PIN1 degradation in various cancer cells. PIN1 degrader-2 covalently modifies PIN1 Cys113. PIN1 degrader-2 also reduces the cell viability of pancreatic cancer, breast cancer, prostate cancer and lung cancer cells. PIN1 degrader-2 can be used in research related to pancreatic cancer, breast cancer, prostate cancer and non-small cell lung cancer [1].
Cat. No.: HY-186218
CAS No.: 3083422-10-7
PROTAC PIN1 degrader-2 is a PROTAC PIN1 degrader. PROTAC PIN1 degrader-2 reduces PIN1-mediated oncogene expression, upregulates PIN1-inhibited tumor suppressor genes, and exerts killing effects on cancer cells. PROTAC PIN1 degrader-2 inhibits tumor growth in breast cancer mouse xenograft models. PROTAC PIN1 degrader-2 can be used for the research of breast cancer [1].
Cat. No.: HY-168037A
PROTAC PIN1 degrader-1 TFA is a PIN1-target PROTAC degrader. PROTAC PIN1 degrader-1 TFA can be used for the research of triple-negative breast cancer, pancreatic cancer, and liver cancer [1].
Cat. No.: HY-145880
CAS No.: 2906180-02-5
Elongation factor P-IN-1 is a potent inhibitor elongation factor P (EFP). Elongation factor P-IN-1 is a β-lysine derivative compound. Elongation factor P-IN-1 affects the proliferation rates of E. coli [1].
Cat. No.: HY-147710
CAS No.: 2417101-28-9
PIN1 inhibitor 2 (compound 12) is a potent PIN1 inhibitor. PIN1 inhibitor 2 shows antitumor activity with an IC50 of 9.55 µM for MCF7 cells. PIN1 inhibitor 2 has the potential for the research of breast cancer [1].
Cat. No.: HY-19771
CAS No.: 1819986-22-5
Synonyms: GSK294; amyloid P-IN-1
Target:
Research Areas:
GSK3039294 is an orally active pro-drug of Miridesap (HY-101861), a circulating serum amyloid P component depleter. GSK3039294 undergoes hydrolysis to form miridesap via a monoester intermediate. GSK3039294 can be used for the research of systemic amyloidosis [1].
Cat. No.: HY-170429
CAS No.: 2468783-22-2
BJP-07-017-3 is the inhibitor for proline cis trans isomerase (Pin1) with an IC50 of 9 nM. BJP-07-017-3 forms covalent bond with Cys113 of Pin1, induces conformational changes in Pin1, reduces its stability, and leads to a proteasome-dependently degradation [1].
Cat. No.: HY-RS23468
Target:
Research Areas:
Pin1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Pin1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-171442A
Research Areas:
(R)-PIN1 ligand-2 is a PIN1 ligand, and can be used for synthesis of PROTACs, such as P1D-34 (HY-171334A) [1].
Cat. No.: HY-168872
CAS No.: 162320-41-4
API32 is a potent Pin1 inhibitor. API32 interactes with the Pin1 PPIase domain. API32 inhibits cell proliferation and migration. API32 has the potential for the research of hepatocellular carcinoma (HCC) [1].
Cat. No.: HY-143903
CAS No.: 2883498-73-3
ZL-Pin13 is a high potent cell-active covalent inhibitor targeting the Pin1 (Peptidyl-Prolyl Isomerase NIMA-Interacting-1) with an IC50 of 67 nM. ZL-Pin13 effectively inhibits the proliferation and downregulated the Pin1 substrates in MDA-MB-231 cells [1].
Cat. No.: HY-184932
PIN1-IN-8 is a covalent inhibitor of Pin1, with IC50 values of 4.19 μM and 1.54 μM against purified Pin1 and Pin1 enzymatic activity, respectively. PIN1-IN-7 exerts antiproliferative effects and induces apoptosis by downregulating c-Myc and Cyclin D1. PIN1-IN-7 can be used in the research of triple-negative breast cancer [1].
Cat. No.: HY-P4202A
Synonyms: Suc-AEPF-pNA TFA
Target:
Research Areas:
Target:
Research Areas:
BCPA is a Pin1 regulator without cytotoxicity. BCPA attenuates the reduction of Pin1 protein to inhibit receptor activator of RANKL-induced osteoclastogenesis. BCPA regulates osteoclast activation, used to osteoporosis research [1].
Cat. No.: HY-P3480
CAS No.: 202739-41-1
Target:
Research Areas:
Cat. No.: HY-171334A
Research Areas:
P1D-34 is a potent PIN1 PROTAC degrader with a DC50 of 177 nM. P1D-34 induces PIN1 degradation in a proteasome- and ubiquitination-like modification-dependent manner, thereby increasing intracellular ROS levels, downregulating the unfolded protein response pathway, and inducing DNA damage, cell cycle arrest and apoptosis. P1D-34 can be used in studies related to acute myeloid leukemia [1] .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
